Guidance for industry : waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2000] |
| Description | 1 electronic resource (13 p.) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS120576 |
| Subjects |
| Portion of title | Waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system |
| General note | "BP." |
| General note | "August 2000." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:B 52/7 |